The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema

被引：0

作者：

Maria Vittoria Cicinelli

Amir Rosenblatt

Domenico Grosso

Piero Zollet

Luigi Capone

Alessandro Rabiolo

Rosangela Lattanzio

Anat Loewenstein

Francesco Bandello

机构：

[1] Vita-Salute San Raffaele University,School of Medicine

[2] IRCCS San Raffaele Scientific Institute,Department of Ophthalmology

[3] Tel-Aviv Sourasky Medical Center,Division of Ophthalmology

[4] Tel-Aviv University,Sackler Faculty of Medicine

[5] Gloucestershire Hospitals NHS Foundation Trust,Department of Ophthalmology

[6] Ophthalmological Unit,Department of Clinical Sciences and Community Health

[7] Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico,Department of Medical Retina

[8] University of Milan,Department of Medical Retina

[9] Singapore National Eye Centre,Smt. Kanuri Santhamma Retina Vitreous Centre LV

[10] Singapore Eye Research Institute,Department of Ophthalmology

[11] Duke-NUS Medical School,Service d’ophtalmologie

[12] Aneurin Bevan University Health Board,Kaplan Medical Centre, department of ophthalmology

[13] Prasad Eye Institute,Department of Ophthalmology

[14] University of British Columbia,Department of Retina and Vitreous

[15] hôpital Avicenne DHU Sight Restore,Department of ophthalmology

[16] Affiliated to Hadassah School of medicine,Charité – Universitätsmedizin Berlin

[17] Cantonal Hospital Lucerne,Centre for Vision Research

[18] Moorfields Eye Hospital NHS Foundation Trust,Department of Ophthalmology

[19] UCL Institute of Health Informatics,Department of Ophthalmology

[20] NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology,2nd Department of Ophthalmology

[21] Clínica de Oftalmología de Cali,Department of Ophthalmology

[22] Ophthalmic department Fondazione Policlinico Universitario Agostino Gemelli IRCCS,State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center

[23] Università Cattolica del Sacro Cuore,Department of Ophthalmology

[24] Pitié Salpêtrière University Hospital Sorbonne Université,Department of Ophthalmology

[25] Clínica oftalmológica Santa Lucía,Department of Ophthalmology

[26] corporate member of Freie Universität Berlin Humboldt Universität zu Berlin,undefined

[27] and Berlin Institute of Health,undefined

[28] The Westmead Institute for Medical Research University of Sydney,undefined

[29] Altino Ventura Foundation,undefined

[30] HOPE Eye Hospital,undefined

[31] Attikon Hospital National and Kapodistrian University of Athens,undefined

[32] Faculty of Medicine Siriraj Hospital Mahidol University,undefined

[33] Department of Ophthalmology Puerta de Hierro-Majadahonda University Hospital,undefined

[34] Ocular Microsurgery Institute (IMO),undefined

[35] Sun Yat-sen University,undefined

[36] Yeni Yuzyil University,undefined

[37] Department of Ophthalmology,undefined

[38] Ludwig-Maximilians-University,undefined

[39] National University of Malaysia,undefined

[40] University of Buenos Aires,undefined

来源：

Eye | 2021年 / 35卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3232 / 3242

页数：10

共 50 条

[31] Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
William Fusi-Rubiano
Rebecca R. Blow
Mark Lane
Rupal Morjaria
Alastair K. Denniston
Ophthalmology and Therapy, 2018, 7 : 293 - 305
[32] Real-world experience with fluocinolone acetonide intravitreal implant in patients with diabetic macular edema
Capone, Luigi
Airaghi, Pietro
Aragona, Pasquale
Castellino, Nicolo
Cicinelli, Maria Vittoria
Ciucci, Francesco
Coppola, Michele
De Gaetano, Cristiano
Lattanzio, Rosangela
Lorusso, Massimo
Maceroni, Martina
Malvasi, Maria Elena
Marco, Luisa
Marraffa, Michele
Martini, Gaia
Mastropasqua, Rodolfo
Minnella, Angelo Maria
Nikolopulou, Eleni
Ortisi, Elina
Pacella, Elena
Papa, Vincenzo
Pennesi, Claudio
Reibaldi, Michele
Rizzo, Stanislao
Toto, Lisa
Trombetta, Luigi
Bandello, Francesco
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (06) : 1837 - 1842
[33] Rapid response to dexamethasone intravitreal implant in diabetic macular edema
Lo Giudice, Giuseppe
Avarello, Antonio
Campana, Gianluca
Galan, Alessandro
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2018, 28 (01) : 74 - 79
[34] Dexamethasone Intravitreal Implant for Diabetic Macular Edema
Panozzo, Giacomo
Gusson, Elena
Casati, Stefano
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[35] Fluocinolone acetonide (0.19 mg) intravitreal implant reduces treatment burden and improves practice resource utilisation for patients with diabetic macular oedema
Byun, Matthew
Osher, James
Riemann, Christopher D.
BMJ OPEN OPHTHALMOLOGY, 2020, 5 (01):
[36] Intravitreal Fluocinolone Acetonide (ILUVIEN) Implant for the Treatment of Refractory Cystoid Macular Oedema After Retinal Detachment Repair
Alfaqawi, Fadi
Sarmad, Ambreen
Ayesh, Kholoud
Mitra, Arijit
Sharma, Ash
TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2018, 48 (03): : 155 - 157
[37] What have we learned from a decade treating patients with diabetic macular oedema with 0.19 mg fluocinolone acetonide intravitreal implant?
Kodjikian, Laurent
Duarte, Lilianne
Singh, Pankaj
Habib, Maged
Gonzalez, Victor
EYE, 2025, : 1238 - 1248
[38] Fluocinolone Acetonide Intravitreal Implant in the Visual Axis
Moisseiev, Elad
Morse, Lawrence S.
JAMA OPHTHALMOLOGY, 2016, 134 (09) : 1067 - 1068
[39] Clinical effectiveness of the fluocinolone acetonide implant in diabetic macular oedema resistant to anti-VEGF therapy
Chalkiadakis, Spyridon E.
Harris, Fiona J.
Taylor, Simon
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
[40] Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
William Fusi-Rubiano
Rebecca R. Blow
Mark Lane
Rupal Morjaria
Alastair K. Denniston
Ophthalmology and Therapy, 2020, 9 : 205 - 205

← 1 2 3 4 5 →